Thiamphenicol

DB08621InvestigationalSmall molecule

Thiamphenicol is a semisynthetic derivative of chloramphenicol with a broad spectrum of antibacterial activity. A medication used to treat certain bacterial infections.

Formula / weight: C₁₂H₁₅Cl₂NO₅S · 356.222 g/mol (avg)

Resolves to

Compound

UNIIFLQ7571NPMCAS15318-45-3ChEMBLCHEMBL1236282ChEBI32215PubChem27200KEGGC12853

Clinical / RWD

RxNorm10463ATCJ01BA02ATCJ01BA52

Structure

InChIKeyOTVAEFIXJLOWRX-NXEZZACHSA-NSMILES[H][C@](CO)(NC(=O)C(Cl)Cl)[C@]([H])(O)C1=CC=C(C=C1)S(C)(=O)=O

Targets

P24093draA

What you can answer from here — as of April 02, 2025

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

56Drug interactionsStructured to mechanism, not free text

1Clinical trialPhase, status and sponsor resolved per trial

1Structured indicationCondition, population, route and combination as fields, not prose

6ContraindicationsEach with its own population and attribute set

125Marketed productsAcross 5 countries and 64 labellers

2ATC codesIncluding every combination product, plus 11 drug categories

1+ReferenceStructured and connected to the statements they support

Which drugs share a target with Thiamphenicol, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account